Evidence map›Paper›PMID 34605171›Full record

ArticleInfluenza and other respiratory viruses2022

The importance of influenza vaccination during the COVID-19 pandemic.

John McCauley, Ian G Barr, Terry Nolan, Theodore Tsai, Steven Rockman, Beverly Taylor

Abstract readCase Reports
In one paragraph

Article in Influenza and other respiratory viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The importance of influenza vaccination during the COVID-19 pandemic.Influenza and other respiratory viruses · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

John McCauleyWorldwide Influenza Centre, The Francis Crick Institute, London, UK.ORCID 0000-0002-4744-6347
Ian G BarrWHO Collaborating Centre for Reference and Research on Influenza, VIDRL, Melbourne, Victoria, Australia.ORCID 0000-0002-7351-418X
Terry NolanVaccine and Immunisation Research Group, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Theodore TsaiTakeda Vaccines, Cambridge, Massachusetts, USA.
Steven RockmanDepartment of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Beverly TaylorSeqirus Ltd, Liverpool, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic and the measures taken to mitigate its spread have had a dramatic effect on the circulation patterns of other respiratory viruses, most especially influenza viruses. Since April 2020, the global circulation of influenza has been markedly reduced; however, it is still present in a number of different countries and could pose a renewed threat in the upcoming Northern Hemisphere winter. Influenza vaccination remains the most effective preventive measure that we have at our disposal against influenza infections and should not be ignored for the 2021-2022 season.

Indexed as

COVID-19Influenza, HumanHumansPandemicsSARS-CoV-2VaccinationcoronavirusCOVID-19influenzaSARS-CoV-2vaccination

Identifiers

PMID34605171
PMCPMC8652850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.